Masimo (BSP:M2AS34) Valuation Rank


BSP:M2AS34 Masimo Corp BSP:M2AS34
55 GF Score
Price R$39.00
GF Value R$36.87
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Masimo Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Masimo Valuation Rank Related Terms

BSP:M2AS34
55GF Score
Masimo Corp BSP:M2AS34
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Masimo (BSP:M2AS34) Overvalued in 2026?

Based on GuruFocus' analysis, Masimo stock appears to be overvalued. The current stock price of R$39.00 is trading 5.8% above its estimated GF Value™ of R$36.87. GuruFocus considers Masimo to be Fairly Valued.

Key valuation signals for BSP:M2AS34:

  • Valuation Rank:
  • GF Value™: R$36.87 vs. price of R$39.00 (5.8% above fair value)
  • GF Score™: 55/100 with 9 warning signs

No single metric tells the full story. See the BSP:M2AS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Masimo Business Description

Address 52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
55GF Score

Get the complete analysis for BSP:M2AS34

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$39.00
Price
R$36.87
GF Value